FDA Inspection 1091871 — Boston Medical Center

Boston Medical Center — FEI 1273232

The FDA completed an inspection of Boston Medical Center on May 16, 2019 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 16, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boston, MA (United States)